ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRX Prosus NV

42.70
-2.78 (-6.11%)
21 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Prosus NV EU:PRX Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.78 -6.11% 42.70 42.67 42.735 44.00 42.665 44.00 5,339,112 02:01:17

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

15/07/2009 2:00pm

PR Newswire (US)


Prosus NV (EU:PRX)
Historical Stock Chart


From Mar 2020 to Mar 2025

Click Here for more Prosus NV Charts.
WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Tuesday, August 4, 2009 at 9:00 am EDT to review results for the second quarter ended June 27, 2009. Par will release its financial results on August 4 before the market opens. The earnings release will be available on the Par website at http://www.parpharm.com/. Access to the live webcast can be made via the Company's website at http://www.parpharm.com/. The dial-in numbers for the conference call will be 866-788-0539 for domestic callers and 857-350-1677 for international callers. The passcode is 40463383. A replay of the conference call will be available for two weeks approximately one hour after the call. The dial-in numbers for the replay are 888-286-8010 for domestic callers and 617-801-6888 for international callers. When prompted, the passcode is 95297063. About Par Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit http://www.parpharm.com/. DATASOURCE: Par Pharmaceutical Companies, Inc. CONTACT: Allison Wey, Senior Director, Investor Relations and Corporate Affairs, Par Pharmaceutical Companies, Inc., +1-201-802-4000 Web Site: http://www.parpharm.com/

Copyright

1 Year Prosus NV Chart

1 Year Prosus NV Chart

1 Month Prosus NV Chart

1 Month Prosus NV Chart